Unsolved problems and new medical approaches to otitis media

References

• Marchisio P, Bianchini S, Villani A, et al. Diagnosis and management of acute mastoiditis in a cohort of Italian children. Expert Rev Anti Infect Ther. 2014;12:1541–1548.
   PubMed Web of Science ®Google Scholar
• Marchisio P, Nazzari E, Torretta S, et al. Medical prevention of recurrent acute otitis media: an updated overview. Expert Rev Anti Infect Ther. 2014;12:611–620.
   PubMed Web of Science ®Google Scholar
• Esposito S, Marchisio P, Tenconi R, et al. Antibiotic treatment of acute otitis media in pediatrics. Future Microbiol. 2011;6:485–488.
   PubMed Web of Science ®Google Scholar
• Chiappini E, Mazzantini R, Bruzzese E, et al. Rational use of antibiotics for the management of children’s respiratory tract infections in the ambulatory setting: an evidence-based consensus by the Italian society of preventive and social pediatrics. Paediatr Respir Rev. 2014;15:231–236.
   PubMed Web of Science ®Google Scholar
• Qureishi A, Lee Y, Belfield K, et al. Update on otitis media - prevention and treatment. Infect Drug Resist. 2014;7:15–24.
   PubMed Web of Science ®Google Scholar
• Minovi A, Dazert S. Diseases of the middle ear in childhood. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2014;13:1–29.
   Google Scholar
• Rovers MM, Schilder AG, Zielhuis GA, et al. Otitis media. Lancet. 2004;363:465–473.
   PubMed Web of Science ®Google Scholar
• Leung AKC, Wong AHC. Acute otitis media in children. Recent Pat Inflamm Allergy Drug Discov. 2017;11:32–40.
   PubMed Web of Science ®Google Scholar
• Todberg T, Koch A, Andersson M, et al. Incidence of otitis media in a contemporary Danish National Birth Cohort. PLoS One. 2014;9:e111732.
   PubMed Web of Science ®Google Scholar
• Marom T, Tan A, Wilkinson GS, et al. Trends in otitis media-related health care use in the United States, 2001–2011. JAMA Pediatr. 2014;168:68–75.
   PubMed Web of Science ®Google Scholar
• Fortanier AC, Venekamp RP, Boonacker CW, et al. Pneumococcal conjugate vaccines for preventing acute otitis media in children. Cochrane Database Syst Rev. 2019;5:CD001480. doi: 10.1002/14651858.CD001480.pub5.
   PubMed Web of Science ®Google Scholar
• Norhayati MN, Ho JJ, Azman MY. Influenza vaccines for preventing acute otitis media in infants and children. Cochrane Database Syst Rev. 2017;10:CD010089.
   PubMed Web of Science ®Google Scholar
• Pichichero ME. Ten year study of acute otitis media in Rochester, NY. Pediatr Infect Dis J. 2016;35:1027–1032.
   PubMed Web of Science ®Google Scholar
• Ben-Shimol S, Givon-Lavi N, Leibovitz E, et al. Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV. Clin Infect Dis. 2014;59:1724–1732.
   PubMed Web of Science ®Google Scholar
• Marchisio P, Esposito S, Picca M, et al. Serotypes not included in 13-valent pneumococcal vaccine as causes of acute otitis media with spontaneous tympanic membrane perforation in a geographic area with high vaccination coverage. Pediatr Infect Dis J. 2017;36:521–523.
   PubMed Web of Science ®Google Scholar
• Hanage WP. Serotype-specific problems associated with pneumococcal conjugate vaccination. Future Microbiol. 2008;3:23–30.
   PubMed Web of Science ®Google Scholar
• Murrah KA, Pang B, Richardson S, et al. Nonencapsulated streptococcus pneumoniae causes otitis media during single-species infection and during polymicrobial infection with nontypeable haemophilus influenzae. Pathog Dis. 2015;73:ftu011.
   PubMed Web of Science ®Google Scholar
• Principi N, Camilloni B, Esposito S, ESCMID Vaccine Study Group (EVASG). Influenza immunization policies: which could be the main reasons for differences among countries? Hum Vaccin Immunother. 2018;4(14):684–692.
   Google Scholar
• Kim H, Webster RG, Webby RJ. Influenza virus: dealing with a drifting and shifting pathogen. Viral Immunol. 2018;31:174–183.
   PubMed Web of Science ®Google Scholar
• van Ingen G, le Clercq CMP, Touw CE, et al. Environmental determinants associated with acute otitis media in children: a longitudinal study. Pediatr Res. Epub Aug 17. 2019. DOI:10.1038/s41390-019-0540-3.
   PubMed Web of Science ®Google Scholar
• Uhari M, Mantysaari K, Niemela M. A meta-analytic review of the risk factors for acute otitis media. Clin Infect Dis. 1996;22:1079–1083.
   PubMed Web of Science ®Google Scholar
• Trochoutsou AI, Kloukina V, Samitas K, et al. Vitamin-D in the immune system: genomic and non-genomic actions. Mini Rev Med Chem. 2015;15:953–963.
   PubMed Web of Science ®Google Scholar
• Li HB, Tai XH, Sang YH, et al. Association between vitamin D and development of otitis media: A PRISMA-compliant meta-analysis and systematic review. Medicine (Baltimore). 2016;95:e4739.
   PubMed Web of Science ®Google Scholar
• Marchisio P, Consonni D, Baggi E, et al. Vitamin D supplementation reduces the risk of acute otitis media in otitis-prone children. Pediatr Infect Dis J. 2013;32:1055–1060.
   PubMed Web of Science ®Google Scholar
• Grossman Z, Hadjipanayis A, Stiris T, et al. Vitamin D in European children-statement from the European Academy of Paediatrics (EAP). Eur J Pediatr. 2017;176:829–831.
   PubMed Web of Science ®Google Scholar
• Sempos CT, Heijboer AC, Bikle DD, et al. Vitamin D assays and the definition of hypovitaminosis D: results from the first international conference on controversies in vitamin D. Br J Clin Pharmacol. 2018;84:2194–2207.
   PubMed Web of Science ®Google Scholar
• Sanders ME. Probiotics: definition, sources, selection, and uses. Clin Infect Dis. 2008;46(Suppl. 2):S58–61.
   PubMed Web of Science ®Google Scholar
• Markowiak P, Śliżewska K. Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients. 2017;9:E1021.
   PubMed Web of Science ®Google Scholar
• Scott AM, Clark J, Julien B, et al. Probiotics for preventing acute otitis media in children. Cochrane Database Syst Rev. 2019;6:CD012941.
   PubMedGoogle Scholar
• Marchisio P, Santagati M, Scillato M, et al. Streptococcus salivarius 24SMB administered by nasal spray for the prevention of acute otitis media in otitis-prone children. Eur J Clin Microbiol Infect Dis. 2015;34:2377–2383.
   PubMed Web of Science ®Google Scholar
• Davani-Davari D, Negahdaripour M, Karimzadeh I, et al. Prebiotics: definition, types, sources, mechanisms, and clinical applications. Foods. 2019;8:E92.
   PubMed Web of Science ®Google Scholar
• Cohen R, Martin E, de La Rocque F, et al. Probiotics and prebiotics in preventing episodes of acute otitis media in high-risk children: a randomized, double-blind, placebo-controlled study. Pediatr Infect Dis J. 2013;32:810–814.
   PubMed Web of Science ®Google Scholar
• Ren Y, Sethi RKV, Stankovic KM. Acute otitis media and associated complications in United States emergency departments. Otol Neurotol. 2018;39:1005–1011.
   PubMed Web of Science ®Google Scholar
• Lieberthal AS, Carroll AE, Chonmaitree T, et al. The diagnosis and management of acute otitis media. Pediatrics. 2013;131:e964–999.
   PubMed Web of Science ®Google Scholar
• Marchisio P, Bellussi L, Di Mauro G, et al. Acute otitis media: from diagnosis to prevention. Summary of the Italian guideline. Int J Pediatr Otorhinolaryngol. 2010;74:1209–1216.
   PubMed Web of Science ®Google Scholar
• Kitamura K, Iino Y, Kamide Y, et al. Clinical practice guidelines for the diagnosis and management of acute otitis media (AOM) in children in Japan - 2013 update. Auris Nasus Larynx. 2015;42:99–106.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence (NICE). Otitis media (acute): antimicrobial prescribing. Guidance and guidelines; cited 2019 Nov 10. Available from: https://www.nice.org.uk/guidance/ng91
   Google Scholar
• Damoiseaux RA. Acute otitis media: do not change the Dutch practice guideline [in Dutch]. Ned Tijdschr Geneeskd. 2012;156:A3795.
   PubMedGoogle Scholar
• Del Castillo Martín F, Baquero Artigao F, de la Calle Cabrera T, et al. Consensus document on the aetiology, diagnosis and treatment of acute otitis media [in Spanish]. An Pediatr (Barc). 2012;77:345.e341–348.
   PubMedGoogle Scholar
• Lee HJ, Park SK, Choi KY, et al. Korean clinical practice guidelines: otitis media in children. J Korean Med Sci. 2012;27:835–848.
   PubMed Web of Science ®Google Scholar
• Rybak A, Levy C, Bonacorsi S, et al. Antibiotic resistance of potential otopathogens isolated from nasopharyngeal flora of children with acute otitis media before, during and after pneumococcal conjugate vaccines implementation. Pediatr Infect Dis J. 2018;37:e72–e78.
   PubMed Web of Science ®Google Scholar
• Sunakawa K, Farrell DJ. Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children. Ann Clin Microbiol Antimicrob. 2007;6:7.
   PubMedGoogle Scholar
• Thornton RB, Rigby PJ, Wiertsema SP, et al. Multi-species bacterial biofilm and intracellular infection in otitis media. BMC Pediatr. 2011;11:94.
   PubMed Web of Science ®Google Scholar
• Mizrahi A, Cohen R, Varon E, et al. Non typeable-haemophilus influenzae biofilm formation and acute otitis media. BMC Infect Dis. 2014;14:400.
   PubMed Web of Science ®Google Scholar
• Coticchia JM, Chen M, Sachdeva L, et al. New paradigms in the pathogenesis of otitis media in children. Front Pediatr. 2013;1:52.
   PubMed Web of Science ®Google Scholar
• Hamilos DL. Biofilm formations in pediatric respiratory tract infection: part 1: biofilm structure, role of innate immunity in protection against and response to biofilm, methods of biofilm detection, pediatric respiratory tract diseases associated with mucosal biofilm formation. Curr Infect Dis Rep. 2019;21:6.
   PubMed Web of Science ®Google Scholar
• Ciofu O, Rojo-Molinero E, Macià MD, et al. Antibiotic treatment of biofilm infections. APMIS. 2017;125:304–319.
   PubMed Web of Science ®Google Scholar
• Hamilos DL. Biofilm formations in pediatric respiratory tract infection part 2: mucosal biofilm formation by respiratory pathogens and current and future therapeutic strategies to inhibit biofilm formation or eradicate established biofilm. Curr Infect Dis Rep. 2019;21:8.
   PubMed Web of Science ®Google Scholar
• Jurcisek JA, Bookwalter JE, Baker BD, et al. The PilA protein of non-typeable haemophilus influenzae plays a role in biofilm formation, adherence to epithelial cells and colonization of the mammalian upper respiratory tract. Mol Microbiol. 2007;65:1288–1299.
   PubMed Web of Science ®Google Scholar
• Blasi F, Page C, Rossolini GM, et al. The effect of N-acetylcysteine on biofilms: implications for the treatment of respiratory tract infections. Respir Med. 2016;117:190–197.
   PubMed Web of Science ®Google Scholar
• Marchisio P, Esposito S, Picca M, et al. Prospective evaluation of the aetiology of acute otitis media with spontaneous tympanic membrane perforation. Clin Microbiol Infect. 2017;23:486.
   PubMed Web of Science ®Google Scholar
• Marchisio P, Esposito S, Bianchini S, et al. Efficacy of injectable trivalent virosomal-adjuvanted inactivated influenza vaccine in preventing acute otitis media in children with recurrent complicated or noncomplicated acute otitis media. Pediatr Infect Dis J. 2009;28:855–859.
   PubMed Web of Science ®Google Scholar
• Esposito S, Marchisio P, Orenti A, et al. Genetic polymorphisms of functional candidate genes and recurrent acute otitis media with or without tympanic membrane perforation. Medicine (Baltimore). 2015;94:e1860.
   PubMed Web of Science ®Google Scholar
• Rybak A, Levy C, Bonacorsi S, et al. Antibiotic resistance of potential otopathogens isolated from nasopharyngeal flora of children with acute otitis media before, during and after pneumococcal conjugate vaccines implementation. Pediatr Infect Dis J. 2018;37:e72–e78.
   PubMed Web of Science ®Google Scholar
• Abdelbary AA, Abd-Elsalam WH, Al-Mahallawi AM. Fabrication of levofloxacin polyethylene glycol decorated nanoliposomes for enhanced management of acute otitis media: statistical optimization, trans-tympanic. permeation and in vivo evaluation. Int J Pharm. 2019 Mar;25(559):201–209.
   Google Scholar
• Kurabi A, Schaerer D, Chang L, et al. Optimisation of peptides that actively cross the tympanic membrane by random amino acid extension: a phage display study. J Drug Target. 2018;26:127–134.
   PubMed Web of Science ®Google Scholar
• Principi N, Esposito S. Experimental and investigational drugs for the treatment of acute otitis media. Expert Opin Investig Drugs. 2019;28:687–694.
   PubMed Web of Science ®Google Scholar
• Mills R, Hathorn I. Aetiology and pathology of otitis media with effusion in adult life. J Laryngol Otol. 2016;130:418–424.
   PubMed Web of Science ®Google Scholar
• Tos M. Epidemiology and natural history of secretory otitis. Am J Otol. 1984;5:459–462.
   PubMedGoogle Scholar
• Hoffman HJ, Daly KA, Bainbridge KE, et al. Panel 1: epidemiology, natural history, and risk factors. Otolaryngol Head Neck Surg. 2013;148(4 Suppl):E1–E25.
   PubMedGoogle Scholar
• Vanneste P, Page C. Otitis media with effusion in children: pathophysiology, diagnosis, and treatment. A review. A review. J Otol. 2019;14:33–39.
   PubMedGoogle Scholar
• Principi N, Marchisio P, Esposito S. Otitis media with effusion: benefits and harms of strategies in use for treatment and prevention. Expert Rev Anti Infect Ther. 2016;14:415–423.
   PubMed Web of Science ®Google Scholar
• Wang DE, Lam DJ, Bellmunt AM, et al. Intranasal steroid use for otitis media with effusion: ongoing opportunities for quality improvement. Otolaryngol Head Neck Surg. 2017;157:289–296.
   PubMed Web of Science ®Google Scholar
• Sajisevi M, Schulz K, Cyr DD, et al. Nonadherence to guideline recommendations for tympanostomy tube insertion in children based on mega-database claims analysis. Otolaryngol Head Neck Surg. 2017;156:87–95.
   PubMed Web of Science ®Google Scholar
• Simon F, Haggard M, Rosenfeld RM, et al. International consensus (ICON) on management of otitis media with effusion in children. Eur Ann Otorhinolaryngol Head Neck Dis. 2018;135(1S):S33–S39.
   PubMed Web of Science ®Google Scholar
• Rosenfeld RM, Shin JJ, Schwartz SR, et al. Clinical practice guideline: otitis media with effusion executive summary (Update). Otolaryngol Head Neck Surg. 2016;154:201–214.
   PubMed Web of Science ®Google Scholar
• Simon F, Haggard M, Rosenfeld RM, et al. International consensus (ICON) on management of otitis media with effusion in children. Eur Ann Otorhinolaryngol Head Neck Dis. 2018;135(Suppl. 1):S33–S39.
   PubMed Web of Science ®Google Scholar
• Perera R, Glasziou PP, Heneghan CJ, et al. Autoinflation for hearing loss associated with otitis media with effusion. Cochrane Database Syst Rev. 2013;5:CD006285.
   Google Scholar
• Steele DW, Adam GP, Di M, et al. Effectiveness of tympanostomy tubes for otitis media: a meta-analysis. Pediatrics. 2017;139:e20170125.
   PubMed Web of Science ®Google Scholar
• Schilder AG, Marom T, Bhutta MF, et al. Panel 7: otitis media: treatment and complications. Otolaryngol Head Neck Surg. 2017;156(Suppl. 4):S88–S105.
   PubMedGoogle Scholar
• Bhat V, Paraekulam Mani I, Aroor R, et al. Association of asymptomatic otitis media with effusion in patients with adenoid hypertrophy. J Otol. 2019;14:106–110.
   PubMedGoogle Scholar
• Hoa M, Syamal M, Schaeffer MA, et al. Biofilms and chronic otitis media: an initial exploration into the role of biofilms in the pathogenesis of chronic otitis media. Am J Otolaryngol. 2010;31:241–245.
   PubMed Web of Science ®Google Scholar
• Saylam G, Tatar EC, Tatar I, et al. Association of adenoid surface biofilm formation and chronic otitis media with effusion. Arch Otolaryngol Head Neck Surg. 2010;136:550–555.
   PubMedGoogle Scholar
• Saafan ME, Ibrahim WS, Tomoum MO. Role of adenoid biofilm in chronic otitis media with effusion in children. Eur Arch Otorhinolaryngol. 2013;270:2417–2425.
   PubMed Web of Science ®Google Scholar
• Hall-Stoodley L, Hu FZ, Gieseke A, et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA. 2006;296:202–211.
   PubMed Web of Science ®Google Scholar
• Emami A, Pirbonyeh N, Moattari A, et al. Risk of otitis media with effusion (OME) in children by Pseudomonas aeruginosa. Int J Pediatr Otorhinolaryngol. 2019;125:6–10.
   PubMed Web of Science ®Google Scholar
• Zanin M, Baviskar P, Webster R, et al. The interaction between respiratory pathogens and mucus. Cell Host Microbe. 2016;19:159–168.
   PubMed Web of Science ®Google Scholar
• Lin J, Tsuboi Y, Rimell F, et al. Expression of mucins in mucoid otitis media. J Assoc Res Otolaryngol. 2003;4:384–393.
   PubMed Web of Science ®Google Scholar
• Kerschner JE, Hong W, Khampang P. Johnston N Differential response of gel-forming mucins to pathogenic middle ear bacteria. Int J Pediatr Otorhinolaryngol. 2014;78:1368–1373.
   PubMed Web of Science ®Google Scholar
• Krueger A, Val S, Pérez-Losada M, et al. Relationship of the middle ear effusion microbiome to secretory mucin production in pediatric patients with chronic otitis media. Pediatr Infect Dis J. 2017;36:635–640.
   PubMed Web of Science ®Google Scholar
• Samuels TL, Yan JC, Khampang P, et al. Association of gel-forming mucins and aquaporin gene expression with hearing loss, effusion viscosity, and inflammation in otitis media with effusion. JAMA Otolaryngol Head Neck Surg. 2017;143:810–817.
   PubMed Web of Science ®Google Scholar
• Alles R, Parikh A, Hawk L, et al. The prevalence of atopic disorders in children with chronic otitis media with effusion. Pediatr Allergy Immunol. 2001;12:102–106.
   PubMed Web of Science ®Google Scholar
• Luong A, Roland PS. The link between allergic rhinitis and chronic otitis media with effusion in atopic patients. Otolaryngol Clin North Am. 2008;41:311–323.
   PubMed Web of Science ®Google Scholar
• Kwon C, Lee HY, Kim MG, et al. Allergic diseases in children with otitis media with effusion. Int J Pediatr Otorhinolaryngol. 2013;77:158–161.
   PubMed Web of Science ®Google Scholar
• Kreiner-Møller E, Chawes BL, Caye-Thomasen P, et al. Allergic rhinitis is associated with otitis media with effusion: a birth cohort study. Clin Exp Allergy. 2012;42:1615–1620.
   PubMed Web of Science ®Google Scholar
• Pau BC, Ng DK. Prevalence of otitis media with effusion in children with allergic rhinitis, a cross sectional study. Int J Pediatr Otorhinolaryngol. 2016;84:156–160.
   PubMed Web of Science ®Google Scholar
• Petrou S, Dakin H, Abangma G, et al. Costutility analysis of topical intranasal steroids for otitis media with effusion based on evidence from the GNOME trial. Value Health. 2010;13:543–551.
   PubMed Web of Science ®Google Scholar
• Simpson SA, Lewis R, van der Voort J, et al. Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev. 2011;5:CD001935.
   PubMed Web of Science ®Google Scholar
• El-Anwar M, Nofal A, Khazbak A, et al. The efficacy of nasal steroids in treatment of otitis media with effusion: a comparative study. Int Arch Otorhinolaryngol. 2015;19:298–301.
   PubMed Web of Science ®Google Scholar
• Gluth MB, McDonald DR, Weaver AL, et al. Management of eustachian tube dysfunction with nasal steroid spray: a prospective, randomized, placebo-controlled trial. Arch Otolaryngol Head Neck Surg. 2011;137:449–455.
   PubMedGoogle Scholar
• Chonmaitree T, Saeed K, Uchida T, et al. A randomized, placebo-controlled trial of the effect of antihistamine or corticosteroid treatment in acute otitis media. J Pediatr. 2003;143:377–385.
   PubMed Web of Science ®Google Scholar
• Coleman C, Moore M. Decongestants and antihistamines for acute otitis media in children. Cochrane Database Syst Rev. 2008;3:CD001727.
   Google Scholar
• Griffin G, Flynn CA, Bailey RE, et al. Antihistamines and/or decongestants for otitis media with effusion (OME) in children. Cochrane Database Syst Rev. 2006;4:CD003423.
   Google Scholar
• Akcan FA, Dündar Y, Akcan HB, et al. Clinical role of vitamin D in prognosis of otitis media with effusion. Int J Pediatr Otorhinolaryngol. 2018;105:1–5.
   PubMed Web of Science ®Google Scholar
• Verhoeff M, van der Veen EL, Rovers MM, et al. Chronic suppurative otitis media: a review. Int J Pediatr Otorhinolaryngol. 2006;70:1–12.
   PubMed Web of Science ®Google Scholar
• Homøe P, Kværner K, Casey JR, et al. Panel 1: epidemiology and diagnosis. Otolaryngol Head Neck Surg. 2017;156(Suppl. 4):S1–S21.
   PubMedGoogle Scholar
• World Health Organization. Chronic suppurative otitis media. Burden of Illness and Management Options. cited 2019 Nov 10. Available from: https://apps.who.int/iris/bitstream/handle/10665/42941/9241591587.pdf
   Google Scholar
• Principi N, Marchisio P, Rosazza C, et al. Acute otitis media with spontaneous tympanic membrane perforation. Eur J Clin Microbiol Infect Dis. 2017;36:11–18.
   PubMed Web of Science ®Google Scholar
• Macfadyen CA, Acuin JM, Gamble C. Systemic antibiotics versus topical treatments for chronically discharging ears with underlying eardrum perforations. Cochrane Database Syst Rev. 2006;1:CD005608.
   PubMedGoogle Scholar
• Morris P. Chronic suppurative otitis media. BMJ Clin Evid. 2012;2012:0507.
   PubMedGoogle Scholar
• Panchasara A, Singh A, Mandavia D, et al. Efficacy and safety of ofloxacin and its combination with dexamethasone in chronic suppurative otitis media. A randomised, double blind, parallel group, comparative study. Acta Otorhinolaryngol Ital. 2015;35:39–44.
   PubMed Web of Science ®Google Scholar
• Mittal A, Mann SB, Panda NK, et al. Secondary fungal infections in chronic suppurative otitis media. Indian J Otolaryngol Head Neck Surg. 1997;49:112–116.
   PubMedGoogle Scholar
• Brennan‐Jones CG, Chong LY, Head K, et al. Topical antibiotics with steroids for chronic suppurative otitis media. Cochrane Database Syst Rev. 2018;6:CD013054.
   Google Scholar
• Koo H, Allan RN, Howlin RP, et al. Targeting microbial biofilms: current and prospective therapeutic strategies. Nat Rev Microbiol. 2017;15:740–755.
   PubMed Web of Science ®Google Scholar
• Xie J, Zhang Y, Caro-Aguilar I, et al. Immunogenicity comparison of a next generation pneumococcal conjugate vaccine in animal models and human infants. Pediatr Infect Dis J. Epub Nov 7. 2019. DOI:10.1097/INF.0000000000002522.
   Web of Science ®Google Scholar
• Thompson A, Lamberth E, Severs J, et al. Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults. Vaccine. 2019;37:6201–6207.
   PubMed Web of Science ®Google Scholar
• Ginsburg AS, Nahm MH, Khambaty FM, et al. Issues and challenges in the development of pneumococcal protein vaccines. Expert Rev Vaccines. 2012;11:279–285.
   PubMed Web of Science ®Google Scholar
• Prymula R, Szenborn L, Silfverdal SA, et al. Safety, reactogenicity and immunogenicity of two investigational pneumococcal protein-based vaccines: results from a randomized phase II study in infants. Vaccine. 2017;35(35Pt B):4603–4611.
   PubMed Web of Science ®Google Scholar
• Sautto GA, Kirchenbaum GA, Ross TM. Towards a universal influenza vaccine: different approaches for one goal. Virol J. 2018;15:17.
   PubMed Web of Science ®Google Scholar
• Wang Y, Deng L, Kang SM, et al. Universal influenza vaccines: from viruses to nanoparticles. Expert Rev Vaccines. 2018;17:967–976.
   PubMed Web of Science ®Google Scholar
• Gerretsen HE, Sande CJ. Development of respiratory syncytial virus (RSV) vaccines for infants. J Infect. 2017;74(Suppl 1):S143–S146.
   PubMedGoogle Scholar
• Esposito S, Pietro GD. Respiratory syncytial virus vaccines: an update on those in the immediate pipeline. Future Microbiol. 2016;11:1479–1490.
   PubMed Web of Science ®Google Scholar